Last reviewed · How we verify

NCT07171918

Prospective Observational Study to Compare REMS vs NEWS2 for Patients Presenting to the ED With Sepsis

Completed Last updated 15 September 2025
What this trial tests

trial testing Antibiotics, Vasopressors in Sepsis in 130 participants. Completed in 31 December 2024.

Timeline
1 January 2023
Primary endpoint
30 June 2024
31 December 2024

Quick facts

Lead sponsorJubilee Mission Medical College and Research Institute
StatusCompleted
Study typeOBSERVATIONAL
Enrollment130
Start date1 January 2023
Primary completion30 June 2024
Estimated completion31 December 2024
Sites1 location across India

Drugs / interventions tested

Conditions studied

Sponsor

Jubilee Mission Medical College and Research Institute

Who can join

18 and older, any sex, with Sepsis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Prospective observational study to determine the utility of Rapid Emergency Medicine Score (REMS) in comparison to National Early Warning Score2 (NEWS2) for predicting morbidity and mortality among patients presenting to the Emergency Department with clinical suspicion of Sepsis

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Sepsis

Currently open trials in the same condition.

Other Jubilee Mission Medical College and Research Institute trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07171918.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing